- Location
Breast Cancer Drug
"-
Acupuncture Works No Better Than "Sham" Version of Technique in Breast-Cancer Drug Study
Dec 26, 2013When it comes to easing the side effects of certain breast cancer drugs, acupuncture may work no better than a "sham" version of the technique, a small trial suggests. Breast cancer drugs known as aromatase inhibitors often cause side ...
Tags: breast cancer, breast cancer drugs, acupuncture, women health
-
IBM Research and IBN Discover Deliver Treatment More Efficiently to Fight Breast Cancer
Nov 5, 2013Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
-
EU's Committee for Medicinal Products for Human Use Has Issued a Positive Opinion
Sep 25, 2013Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
-
Biocon Is Sure Herceptin Biosimilar Version Will Be Launched This Year
Aug 26, 2013India-based Biocon is likely to launch the Swiss drugmaker Roche's Herceptin (trastuzumab) biosimilar version by the end of 31 March 2014, following the latter's decision to give up a patent fight over the breast cancer drug in the country. ...
-
India Partly Suspended Patents Granted to Roche Holding for Breast Cancer Drug Herceptin
Aug 6, 2013India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...
Tags: Cancer Drug Patent
-
Pfizer Has Received Breakthrough Therapy Designation From The U.S FDA
Apr 15, 2013Pfizer has received breakthrough therapy designation from the United States Food and Drug Administration (FDA) for its investigational compound Palbociclib, a potential treatment for patients with breast cancer. The breakthrough therapy ...
Tags: Cancer Drug, Pfizer, Therapy Designation
-
NICE in The UK, Has Issued an Appraisal Consultation Document (ACD)
Mar 26, 2013The National Institute for Health and Clinical Excellence (NICE) in the UK, has issued an Appraisal Consultation Document (ACD) recommending that Afinitor (everolimus), a Novartis’ life extending advanced breast cancer treatment ...
